Montelukast Tablet, Film Coated
Product Images NDC 72865-175

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Montelukast (NDC 72865-175). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Xlcare Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure1.jpg (Figure1)

FDA Label Image

Figure2.jpg (Figure2)

FDA Label Image

Montesodtab10mg30scount (Montesodtab10mg30scount)

Montesodtab10mg30scount (Montesodtab10mg30scount)
This is a description of a medication called Montelukast Sodium tablets, USP, manufactured by XLCare Pharmaceuticals, Inc. Each film-coated tablet contains 10.4 mg Montelukast Sodium USP equivalent to 10 mg Montelukast. This medication is intended for use in adults aged 15 years and older, and comes in a package of 30 tablets. The dosage instructions are provided in the package insert, which is given to each patient. It must be stored at a temperature between 20° to 25°C (68° to 77°F), protected from moisture and light, and in its original package. The contact number for further inquiries is 1-866-495-1995.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.